Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Discovery and development of biopharmaceuticals: current issues.

Literature DB >> 19896824

Discovery and development of biopharmaceuticals: current issues.

William R Strohl, David M Knight.

Abstract

Mesh：

Substances：

Year: 2009 PMID： 19896824 DOI： 10.1016/j.copbio.2009.10.012

Source DB: PubMed Journal: Curr Opin Biotechnol ISSN： 0958-1669 Impact factor: 9.740

Keyword Cloud
Cited

× No keyword cloud information.

26 in total

Review 1. Strategies and challenges for the next generation of therapeutic antibodies.

Authors: Alain Beck; Thierry Wurch; Christian Bailly; Nathalie Corvaia
Journal: Nat Rev Immunol Date: 2010-05 Impact factor: 53.106

2. Galactosylation variations in marketed therapeutic antibodies.

Authors: T Shantha Raju; Robert E Jordan
Journal: MAbs Date: 2012-04-26 Impact factor: 5.857

Review 3. To fuse or not to fuse: what is your purpose?

Authors: Mark R Bell; Mark J Engleka; Asim Malik; James E Strickler
Journal: Protein Sci Date: 2013-09-17 Impact factor: 6.725

4. Computational design of an endo-1,4-beta-xylanase ligand binding site.

Authors: Andrew Morin; Kristian W Kaufmann; Carie Fortenberry; Joel M Harp; Laura S Mizoue; Jens Meiler
Journal: Protein Eng Des Sel Date: 2011-02-24 Impact factor: 1.650

5. Effects of clonal variation on growth, metabolism, and productivity in response to trophic factor stimulation: a study of Chinese hamster ovary cells producing a recombinant monoclonal antibody.

Authors: Hussain Dahodwala; Mark Nowey; Tatyana Mitina; Susan T Sharfstein
Journal: Cytotechnology Date: 2011-08-06 Impact factor: 2.058

Discovery and development of biopharmaceuticals: current issues.

Review 1. Strategies and challenges for the next generation of therapeutic antibodies.

2. Galactosylation variations in marketed therapeutic antibodies.

Review 3. To fuse or not to fuse: what is your purpose?

4. Computational design of an endo-1,4-beta-xylanase ligand binding site.

5. Effects of clonal variation on growth, metabolism, and productivity in response to trophic factor stimulation: a study of Chinese hamster ovary cells producing a recombinant monoclonal antibody.

6. Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis.

7. Comprehensive engineering of Escherichia coli for enhanced expression of IgG antibodies.

Review 8. Computational design of protein-ligand interfaces: potential in therapeutic development.

9. Arginine topology controls escape of minimally cationic proteins from early endosomes to the cytoplasm.

10. Rapid Glycopeptide Enrichment Using Cellulose Hydrophilic Interaction/Reversed-Phase StageTips.